Investors are looking at the US COVID-19 data as a guide for when markets may settle down. Our view is that it’s going to be tough for markets to find a bottom until it becomes clear that the US understands the scale of its COVID-19 problem and is taking appropriate steps to mitigate. Continue…

by Gary Rollo Posted in Market commentary.

• 2 Comments
• save this article
• 2
• POSTED IN Market commentary.

Small cap discretionary retailers have been among the biggest losers in this market rout.  But, sifting through the wreckage, we’ve found some great businesses that could bounce strongly if the worst-case scenario being priced in by the market turns out better than expected. Continue…

by Dominic Rose Posted in Companies, Consumer discretionary, Stocks We Like.

• save this article
• POSTED IN Companies, Consumer discretionary, Stocks We Like.

by Roger Montgomery's Team Posted in Old Content.

• Enter your password to view comments.
• save this article
• Enter your password to view comments.
• POSTED IN Old Content.

Italy’s major national shutdown and lockdown isolation measures taken on 9 March and March 11, some 14-16 days ago, may now be showing up as lower case numbers.  The timeline appears to fit the proposed initial two week quarantine period suggested for potential COVID-19 cases. Continue…

by Gary Rollo Posted in Market commentary.

• 4 Comments
• save this article
• 4
• POSTED IN Market commentary.

by Roger Montgomery's Team Posted in Old Content.

• Enter your password to view comments.
• save this article
• Enter your password to view comments.
• POSTED IN Old Content.

by Roger Montgomery's Team Posted in Old Content.

• Enter your password to view comments.
• save this article
• Enter your password to view comments.
• POSTED IN Old Content.

by Roger Montgomery's Team Posted in Old Content.

• Enter your password to view comments.
• save this article
• Enter your password to view comments.
• POSTED IN Old Content.

In our third update tracking COVID-19 testing data, NSW Health started reporting data on 25 January. The data released regularly reported case epidemiology, with a high trace rate, as well as good data on disease incidence by age cohort. NSW Health also appeared to have started early with a testing plan, and we note that when that testing regime scored a hit, testing volumes jumped, and kept ramping. Continue…

by Gary Rollo Posted in Market commentary.

• 8 Comments
• save this article
• 8
• POSTED IN Market commentary.